LAVA Therapeutics NV Quarterly Costs and Expenses in USD from Q1 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
LAVA Therapeutics NV quarterly/annual Costs and Expenses history and growth rate from Q1 2024 to Q2 2025.
  • LAVA Therapeutics NV Costs and Expenses for the quarter ending June 30, 2025 was $7.29M, a 22.4% decline year-over-year.
  • LAVA Therapeutics NV annual Costs and Expenses for 2024 was $41.7M, a 16.9% decline from 2023.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $7.29M -$2.1M -22.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $7.59M -$1.44M -16% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q2 2024 $9.39M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $9.03M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.